155 related articles for article (PubMed ID: 21814853)
1. Imaging tumor endothelial marker 8 using an 18F-labeled peptide.
Quan Q; Yang M; Gao H; Zhu L; Lin X; Guo N; Zhang G; Eden HS; Niu G; Chen X
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1806-15. PubMed ID: 21814853
[TBL] [Abstract][Full Text] [Related]
2. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
3. Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts.
Li W; Zheng H; Xu J; Cao S; Xu X; Xiao P
PLoS One; 2018; 13(6):e0199024. PubMed ID: 29894497
[TBL] [Abstract][Full Text] [Related]
4. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
5. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton.
Werner E; Kowalczyk AP; Faundez V
J Biol Chem; 2006 Aug; 281(32):23227-36. PubMed ID: 16762926
[TBL] [Abstract][Full Text] [Related]
6. Effects from metal ion in tumor endothelial marker 8 and anthrax protective antigen: BioLayer Interferometry experiment and molecular dynamics simulation study.
Jia Z; Ackroyd C; Han T; Agrawal V; Liu Y; Christensen K; Dominy B
J Comput Chem; 2017 Jun; 38(15):1183-1190. PubMed ID: 28437008
[TBL] [Abstract][Full Text] [Related]
7. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
8. (64)Cu-labeled peptide for PET of breast carcinomas expressing the Thomsen-Friedenreich carbohydrate antigen.
Kumar SR; Gallazzi FA; Quinn TP; Deutscher SL
J Nucl Med; 2011 Nov; 52(11):1819-26. PubMed ID: 21984800
[TBL] [Abstract][Full Text] [Related]
9. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
[TBL] [Abstract][Full Text] [Related]
10. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli.
Ding Z; Bradley KA; Amin Arnaout M; Xiong JP
Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009
[TBL] [Abstract][Full Text] [Related]
12. PET of malignant melanoma using 18F-labeled metallopeptides.
Ren G; Liu Z; Miao Z; Liu H; Subbarayan M; Chin FT; Zhang L; Gambhir SS; Cheng Z
J Nucl Med; 2009 Nov; 50(11):1865-72. PubMed ID: 19837749
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
14. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
15. Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.
Cryan LM; Habeshian KA; Caldwell TP; Morris MT; Ackroyd PC; Christensen KA; Rogers MS
J Biomol Screen; 2013 Jul; 18(6):714-25. PubMed ID: 23479355
[TBL] [Abstract][Full Text] [Related]
16. TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).
Nanda A; Carson-Walter EB; Seaman S; Barber TD; Stampfl J; Singh S; Vogelstein B; Kinzler KW; St Croix B
Cancer Res; 2004 Feb; 64(3):817-20. PubMed ID: 14871805
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.
Duan HF; Hu XW; Chen JL; Gao LH; Xi YY; Lu Y; Li JF; Zhao SR; Xu JJ; Chen HP; Chen W; Wu CT
J Natl Cancer Inst; 2007 Oct; 99(20):1551-5. PubMed ID: 17925540
[TBL] [Abstract][Full Text] [Related]
18. A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor.
Miao Z; Ren G; Jiang L; Liu H; Webster JM; Zhang R; Namavari M; Gambhir SS; Syud F; Cheng Z
Eur J Nucl Med Mol Imaging; 2011 Nov; 38(11):1977-84. PubMed ID: 21761266
[TBL] [Abstract][Full Text] [Related]
19. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
Liu S; Leppla SH
J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of EGF receptors using [18F]FBEM-EGF in a head and neck squamous cell carcinoma model.
Li W; Niu G; Lang L; Guo N; Ma Y; Kiesewetter DO; Backer JM; Shen B; Chen X
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):300-8. PubMed ID: 22109665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]